Viatris vs Zoetis
VTRS and ZTS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How VTRS and ZTS compare
Zoetis is the larger company, worth 1.5 times as much as Viatris ($32.9B against $21.9B).
Viatris grew revenue faster over the last twelve months (4.4% versus 1.5% for Zoetis).
Both pay dividends: Viatris yields 2.5% and Zoetis 2.6%.
Zoetis scores higher on the StockData Score (17 against 6 for Viatris), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | VTRS | ZTS |
|---|---|---|
| Size and price | ||
| Market cap | $21.9B | $32.9B |
| Share price | $19.04 | $79.72 |
| Change, 1 year | 85.3% | −44.6% |
| Change, 5 years | 38.6% | −63.2% |
| Beta (5Y) | 0.87 | 0.78 |
| Employees | 30K | 15K |
| StockData Score | ||
| Total score | 6 | 17 (better) |
| Valuation score | 2 | 5 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 5 (better) |
| Health score | 1 | 3 (better) |
| Dividend score | 2 | 2 |
| Valuation | ||
| P/E | – | 13.1× |
| P/S | 1.5× (better) | 3.5× |
| P/B | – | 10.5× |
| EV/EBITDA | 12.6× | 10.1× (better) |
| P/FCF | 11.2× (better) | 14.2× |
| PEG | – | 1.28 |
| FCF yield | 8.9% (better) | 7.0% |
| Fair value | $20.87 | $152.11 |
| Margin of safety | 8.8% | 47.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.4% (better) | 1.5% |
| Revenue growth, 5Y average | 3.7% | 7.2% (better) |
| Net income growth (TTM) | – | 0.96% |
| EPS growth (TTM) | – | 5.6% |
| EPS growth, 5Y average | – | 12.0% |
| Profitability | ||
| Gross margin | 34.8% | 71.5% (better) |
| Operating margin | −0.59% | – |
| Net margin | – | 27.5% |
| FCF margin | 13.3% | 24.3% (better) |
| Return on equity | – | 64.4% |
| Financial health | ||
| Debt / equity | – | 2.87 |
| Net debt / EBITDA | 4.59 | 1.85 (better) |
| Interest coverage | −0.2× | – |
| Current ratio | 1.58 | 3.08 (better) |
| Altman Z-score | 1.16 | 3.99 (better) |
| Piotroski F-score | – | 8 |
| Dividends and buybacks | ||
| Dividend yield | 2.5% | 2.6% (better) |
| Years of dividend growth | 0 | 13 (better) |
| Dividend growth, 5Y average | – | 19.0% |
| Buyback yield | 1.4% | 11.1% (better) |
| Shareholder yield | 3.9% | 13.7% (better) |
| Ownership | ||
| Held by institutions | 91.5% | 96.1% |
| Held by insiders | 0.36% | 0.08% |
| Insider net buying, 12 months | −$1.1M (better) | −$1.7M |
| Superinvestors holding | 3 | 3 |
| Short interest, % of float | 3.7% | 4.5% |
Go deeper
- VTRS stock overview
- VTRS income statement
- VTRS valuation and score
- ZTS stock overview
- ZTS income statement
- ZTS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.